Mon, Jun 26, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Hedge fund Finisterre Capital appoints new economist from Credit Suisse

Monday, July 11, 2011
Opalesque Industry Update - Finisterre Capital, the long/short emerging market total return specialist, has appointed Ivailo Vesselinov as an Economist. He will report to Christopher Watson, Head of Research at Finisterre Capital.

Ivailo was previously at Credit Suisse in London, where he was a Director and Senior EMEA Economist. He joined Credit Suisse in 2009 from Dresdner Kleinwort, where he held a similar position. He began his career in 1999 at the Bulgarian National Bank in Sofia as an Analyst. Ivailo holds an MPhil in Macroeconomics from the University of Cambridge.

“Ivailo will be a welcome addition to our team,” said Watson. “He brings with him extensive professional experience as an economic analyst and his appointment will enable us to benefit from a number of trends currently underway in EM and allow us to take advantage of potential growth opportunities.”

(press release)

About Finisterre Capital
Finisterre Capital LLP, founded in 2002, is an Emerging Markets specialist dedicated to delivering risk-controlled, total return investment strategies to the institutional marketplace. The firm manages Emerging Markets funds in a variety of asset classes, including sovereign debt, local currency debt, foreign exchange, corporate credit, special situations and equity.

Finisterre’s funds are all actively managed and include the Sovereign Debt Fund, which uses a top-down macro approach to emerging market sovereign debt; the Global Opportunity Fund, which has a portfolio of sovereign and corporate debt, foreign exchange, interest rates and equity; and the Finisterre Credit Fund, which concentrates on bottom-up corporate credit. In January last year, Finisterre launched the Emerging Markets Fund (FEMF), enabling investors to gain exposure to all Finisterre strategies. Corporate website: Source

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. FinTech - Rise of robots: Inside the world's fastest growing hedge funds[more]

    From Bloomberg.com: Believe the hype. Quants have never been more popular. After doubling over the past decade, assets run by so-called systematic funds have hit a record $500 billion this year, according to estimates from Barclays Plc. In some ways, their meteoric rise is due to the same technolog

  2. Legal - Bond market concerns could scuttle Paulson's Fannie-Freddie plan[more]

    From Bloomberg.com: A hedge fund proposal for freeing Fannie Mae and Freddie Mac from U.S. control is poised to face stiff opposition from investors who say it risks wrecking the mortgage-bond market. The Moelis & Co. blueprint, which firms including Paulson & Co. and Blackstone Group LP sponsored,

  3. Other Voices: Are your pricing policies and procedures for less liquid instruments adequate?[more]

    Komfie Manalo, Opalesque Asia: The unrelated position mismarking incidents that quickly precipitated the closures of both Visium Asset Management and Marinus Capital have been recent focal points for market participants, but regulatory scrutiny of valuation choices for less liquid instruments is

  4. FinTech - AI hedge fund Numerai now live on Ethereum, Cryptocurrency hedge funds generate huge returns as bitcoin surges[more]

    AI hedge fund Numerai now live on Ethereum From Cryptoninjas.net: Back in February, Numerai announced numeraire (NMR), a cryptographic token to incentivize a new kind of hedge fund built by a network of data scientists. Earlier today, the Numeraire smart contract was officially deployed

  5. Investing - Advisors slash hedge fund positions, Theravance Biopharma is a top pick of investment guru Seth Klarman, As asset management industry grows a search for new revenue streams[more]

    Advisors slash hedge fund positions From Barrons.com: Financial advisors have cut wealthy clients' exposure to hedge funds by up to one third over the past 12 months, The Financial Times reports. Advisor firms in the FT's annual top-300 ranking have reduced their hedge fund allocation to